Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: Possible therapeutic targets?

Nitric oxide (NO) is synthetized enzymatically from l-arginine (l-Arg) by three NO synthase isoforms, iNOS, eNOS and nNOS. The synthesis of NO is selectively inhibited by guanidino-substituted analogs of l-Arg or methylarginines such as asymmetric dimethylarginine (ADMA), which results from protein...

Full description

Saved in:
Bibliographic Details
Published in:Pharmacology & therapeutics (Oxford) Vol. 140; no. 3; pp. 239 - 257
Main Authors: Rochette, Luc, Lorin, Julie, Zeller, Marianne, Guilland, Jean-Claude, Lorgis, Luc, Cottin, Yves, Vergely, Catherine
Format: Journal Article
Language:English
Published: Oxford Elsevier 01.12.2013
Subjects:
BH
GTP
AF
AT
ARE
MAO
ERK
SR
HIF
FMN
SOD
CR
CV
TH
PAH
JNK
DM
MDA
UA
CaM
RNS
Prx
Trx
HSP
MT
FOS
GPx
PCD
NOX
CAT
ROS
SAH
SAM
NO
LTL
LDL
DMA
GSH
OS
FAD
GP
ISSN:0163-7258, 1879-016X, 1879-016X, 0163-7258
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first